DSS, INC. (DSS)
AMEX · Wood, Furniture & Paper · Paperboard Containers & Boxes
- Price
- $0.68
- Day
- -2.56%
- Market cap
- $6.8M
Close 2026-09-24.
The company
Overview Impact BioMedical’s IPO, which was finalized in the latter half of 2024, resulted in the company being listed on a recognized public exchange. This public offering raised substantial capital, enabling Impact BioMedical to further accelerate its expansion into cutting-edge biomedical technologies, which align with the growing demand for advanced healthcare solutions. The funds raised from the IPO will be allocated to advancing R&D initiatives, scaling production capabilities, and enhancing market penetration.
From Item 1: Overview · Impact.
By product & service
- Printed Products — 87%
- Commission — 6%
- Rental Income — 6%
- Commercial Lending — 0%
- Biotechnology — 0%
Institutional holders
Largest positions reported on Form 13F for the quarter ended 2026-06-30, by value.
- VANGUARD CAPITAL MANAGEMENT LLC — $34.24K
- UBS Group AG — $19.17K
- RENAISSANCE TECHNOLOGIES LLC — $15.96K
- GEODE CAPITAL MANAGEMENT, LLC — $15.74K
- UBS Group AG — $13.61K
- BlackRock, Inc. — $12.38K
- XTX Topco Ltd — $8.45K
- Tower Research Capital LLC (TRC) — $4.44K
Insider trades
Open-market buys and sales filed on Form 4, newest first. Grants, option exercises and tax withholding are left out.
- Chan Heng Fai Ambrose (Director,TenPercentOwner) sold 21,852 shares at $0.82 on 2026-09-03
- Chan Heng Fai Ambrose (Director,TenPercentOwner) sold 130,679 shares at $1.35 on 2025-08-28
- Chan Heng Fai Ambrose (Director,TenPercentOwner) bought 205,149 shares at $0.97 on 2024-12-10
- Chan Heng Fai Ambrose (Director,TenPercentOwner) bought 820,597 shares at $0.97 on 2024-12-10
Recent filings
- 8-K — 2026-09-21
- 4 — 2026-09-08
- SCHEDULE 13D/A — 2026-09-08
- 424B5 — 2026-09-04
- 10-Q — 2026-08-14
- SCHEDULE 13D/A — 2026-07-09
- 4 — 2026-07-09
- 8-K — 2026-06-25
- 10-Q — 2026-05-15
- DEF 14C — 2026-05-14